Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI

被引:0
|
作者
Su, Min-Ying [1 ]
Baik, Hyun-Man
Yu, Hon J.
Chen, Jeon-hor
Mehta, Rita S.
Nalcioglu, Orhan
机构
[1] Univ Calif Irvine, John Tu & Thomas Yuen Ctr Funct Oncoimaging, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA
关键词
breast cancer; choline; dynamic contrast enhanced MRI; MR spectroscopic imaging; neoadjuvant chemotherapy; and pharmacokinetic parameters;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although an MRI scanner is a single stand-alone modality, different acquisition techniques may be applied to collect structural and functional information, including vascular or angiogenic properties measured by dynamic contrast enhanced MRI (DCE-MRI) and Choline (Cho) metabolism measured by proton MR spectroscopy imaging (MRSI). They may provide complementary information for a better characterization of neoplasm. In this study, we investigated the correlation between Choline measured by MRSI and vascular parameters measured by DCE-MRI in breast cancer. Fourteen patients with histologically proven invasive breast cancer were included. MRSI from a grid of 8 x 8 voxels within a selected slab from each lesion was performed. Each voxel was 1.0 x 1.0 x 1.2 cm(3). Choline signal-to-noise ratio (SNR) was measured from each voxel showing an identifiable Choline peak. Corresponding DCE kinetics was measured from each voxel, and analyzed with a 2-compartmental model to obtain pharmacokinetic parameters K-trans and k(ep). All parameters showed a wide variation within each lesion, and there were no consistent correlations between regional Cho and DCE parameters within the lesion of each individual patient. This finding might be attributed to the heterogeneous nature of breast cancer. The characteristic Cho and DCE-MRI parameters were obtained for each patient by averaging over all Cho-positive voxels. In these 14 patients there was a significant linear correlation between Cho with percent enhancement at 2 min after injection, SE%-2min (r = 0.75, p = 0.002), and pharmacokinetic parameters K-trans (r = 0.74, p = 0.003), and k(ep) (r = 0.76, p = 0.002). The results suggested that overall there is a correlation between Choline metabolism and angiogenesis activity. Since Choline is associated with cell replication and angiogenesis is required to support tumor growth, this might explain the correlation between these two sets of measures among different lesions.
引用
收藏
页码:401 / 410
页数:10
相关论文
共 50 条
  • [31] Correlation of dynamic contrast-enhanced MRI and diffusion-weighted MR imaging with prognostic factors and subtypes of breast cancers
    Chen, Hui
    Li, Wei
    Wan, Chao
    Zhang, Jue
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Contrast-enhanced in vivo imaging of breast and prostate cancer cells by MRI
    Rodriguez, O
    Fricke, S
    Chien, C
    Dettin, L
    VanMeter, J
    Shapiro, E
    Dai, HN
    Casimiro, M
    Ileva, L
    Dagata, J
    Johnson, MD
    Lisanti, MP
    Koretsky, A
    Albanese, C
    CELL CYCLE, 2006, 5 (01) : 113 - 119
  • [33] Breast dispersion imaging using undersampled rapid dynamic contrast-enhanced MRI
    Shi, Linxi
    Srinivasan, Subashini
    Hargreaves, Brian
    Daniel, Bruce
    MEDICAL IMAGING 2019: COMPUTER-AIDED DIAGNOSIS, 2019, 10950
  • [34] Quantitative correlation between 1H MRS and dynamic contrast-enhanced MRI of human breast cancer
    Baek, Hyeon-Man
    Yu, Hon J.
    Chen, Jeon-Hor
    Nalcioglu, Orhan
    Su, Min-Ying
    MAGNETIC RESONANCE IMAGING, 2008, 26 (04) : 523 - 531
  • [35] Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy
    Zhang, Michelle
    Horvat, Joao V.
    Bernard-Davila, Blanca
    Marino, Maria Adele
    Leithner, Doris
    Ochoa-Albiztegui, R. Elena
    Helbich, Thomas H.
    Morris, Elizabeth A.
    Thakur, Sunitha
    Pinker, Katja
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2019, 49 (03) : 864 - 874
  • [36] Differentiation between Luminal A and B Molecular Subtypes of Breast Cancer Using Pharmacokinetic Quantitative Parameters with Histogram and Texture Features on Preoperative Dynamic Contrast-Enhanced Magnetic Resonance Imaging
    Luo, Hong-Bing
    Du, Ming-Ying
    Liu, Yuan-Yuan
    Wang, Min
    Qing, Hao-Miao
    Wen, Zhi-peng
    Xu, Guo-Hui
    Zhou, Peng
    Ren, Jing
    ACADEMIC RADIOLOGY, 2020, 27 (03) : E35 - E44
  • [37] Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
    Xiao, Jennifer
    Rahbar, Habib
    Hippe, Daniel S.
    Rendi, Mara H.
    Parker, Elizabeth U.
    Shekar, Neal
    Hirano, Michael
    Cheung, Kevin J.
    Partridge, Savannah C.
    NPJ BREAST CANCER, 2021, 7 (01)
  • [38] Assessing the reproducibility of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer
    Barnes, Stephanie L.
    Whisenant, Jennifer G.
    Loveless, Mary E.
    Ayers, Gregory D.
    Yankeelov, Thomas E.
    MAGNETIC RESONANCE IN MEDICINE, 2013, 69 (06) : 1721 - 1734
  • [39] Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer
    Su, MY
    Cheung, YC
    Fruehauf, JP
    Yu, H
    Nalcioglu, O
    Mechetner, E
    Kyshtoobayeva, A
    Chen, SC
    Hsueh, S
    McLaren, CE
    Wan, YL
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2003, 18 (04) : 467 - 477
  • [40] Can imaging kinetic parameters of dynamic contrast-enhanced magnetic resonance imaging be valuable in predicting clinicopathological prognostic factors of invasive breast cancer?
    Wang, Cuiyan
    Wei, Wei
    Santiago, Lumarie
    Whitman, Gary
    Dogan, Basak
    ACTA RADIOLOGICA, 2018, 59 (07) : 813 - 821